Receptor activator of nuclear factor B (RANK), a lately identified member of the tumor necrosis factor receptor superfamily, plays important roles both in osteoclastogenesis and in lymph node development. Previously, we and others showed that RANK could stimulate the activity of c-Jun N-terminal kinase (JNK). In this study, we investigated the mechanism by which RANK activates JNK. We found that N-terminal deletion mutants of tumor necrosis factor receptor-associated factor 2 and 6 were inhibitory to RANK activation of JNK. The JNK activation by RANK was also reduced by cotransfection of kinase-inactive mutants of apoptosis signal-regulating kinase 1, MAPK/ERK kinase kinase 1, and nuclear factor B-inducing kinase. In addition, dominant negative mutants of Rac and Ras decreased the RANK stimulation of JNK activity. Furthermore, we determined whether the RANK engagement of JNK signaling pathways could lead to the activation of the activator protein 1 (AP-1) transcription factor, one of the potential downstream targets of activated JNK. RANK was found to activate AP-1 in a manner dependent on the signaling molecules involved in the JNK activation by this receptor. Furthermore, the activation of JNK and ERK, but not that of p38, appeared to be involved in the AP-1 activation by RANK. Thus, RANK may use both JNK and ERK pathways to signal to the AP-1 transcription factor.
Receptor activator of nuclear factor B (RANK) is a recently cloned member of the tumor necrosis factor receptor (TNFR) superfamily, showing 20 to 40% amino acid identity to other TNFR family proteins in its extracellular domain (Anderson et al., 1997) . Several studies have implicated physiological functions of this receptor in the regulation of bone metabolism and the immune system. Stimulation of RANK with its ligand, RANKL [also called ODF (osteoclast differentiation factor), OPGL (osteoprotogerin ligand), and TRANCE (TNF-related activation induced cytokine)], has been shown to induce the differentiation of osteoclasts from hematopoietic progenitors and to deliver activating and survival signals in mature osteoclasts (Fuller et al., 1998; Lacey et al., 1998; Yasuda et al., 1998; Burgess et al., 1999) . The RANKL/RANK interaction has been reported to increase the allostimulatory activity of dendritic cells in a mixed lymphocyte reaction and to provide the costimulation for T helper cell activation in the absence of CD40, which was assumed to be mediated by enhanced dendritic cell function (Anderson et al., 1997; Bachmann et al., 1999) . The mechanism for the RANK-dependent increase of dendritic cell function may be explained by the observation that RANKL/TRANCE up-regulated Bcl-xL expression and inhibited apoptosis of isolated dendritic cells (Wong et al., 1997) .
Many of the TNFR family members share certain biochemical consequences, such as the activation of nuclear factor B (NF-B) and that of c-Jun N-terminal kinase (JNK). In both of these events, direct or indirect recruitment of TNF receptor-associated factor (TRAF) family molecules to the receptor in the plasma membrane appears to be an initial step. We and others have shown that RANK can directly associate with TRAF proteins and activate NF-B and JNK (Anderson et al., 1997; Darnay et al., 1998; Wong et al., 1998; Kim et al., 1999) .
The JNK activation pathway is a cascade of phosphorylation events that involve JNK-activating kinases (JNKK1/ SEK1/MKK4/MEK4 and JNKK2), which, in turn, are activated by JNKK-activating kinases [MEKK1 and MEKK5/ apoptosis signal-regulating kinase 1 (ASK1)]. The JNK activation cascade has been shown to be positively regulated by small GTPases Rac, Cdc42, and Ras (Coso et al., 1995; Minden et al., 1995) , and MEKK1 has been demonstrated to bind those small GTPase proteins (Russell et al., 1995; Fanger et al., 1997) . In some cases, PI 3-kinase is implicated in the Rac-mediated JNK activation (Timokhina et al., 1998) . MEKK1 and ASK1 have been shown to participate in the TNF-induced or TRAF2-mediated JNK activation (Liu et al., 1996; Song et al., 1997; Nishitoh et al., 1998) . For the activation of JNK by TNF-␣ and CD40, TRAF2 has been demonstrated to be essential Yeh et al., 1997) . However, the role of TRAF proteins, JNK-and JNKKKactivating kinases, small GTPases, and PI 3-kinase for the RANK activation of JNK has not been studied to date.
JNK regulates gene expression by phosphorylating and thus activating the transactivation domain of c-Jun in activator protein (AP)-1 complexes, homo-and heterodimers of Jun and Fos family proteins . In addition to NF-B activation, AP-1 activation appears to participate in the TNF regulation of gene expression (Westwick et al., 1994) . However, AP-1 activation by other TNFR family receptors, including RANK, has not been reported, and whether AP-1 activation is a common feature of TNFR family proteins that activate JNK has not been addressed. Because both the rank and the c-fos genes seem to be essential for osteoclast development and RANK can activate JNK, it was intriguing to know whether the RANK signaling to JNK extends to AP-1 activation.
In this study, we determined the involvement of TRAF proteins, JNK-regulating kinases, small GTPases, and PI 3-kinase in the RANK-induced JNK activation and explored the potential linkage of JNK pathway to AP-1 in RANK signaling. The RANK-induced JNK activation appeared to be mediated by TRAF2 and to a less extent by TRAF6. The involvement of ASK1, MEKK1, NIK, and SEK1 was indicated, because the kinase-inactive mutants of these kinases showed dominant negative effects. The dominant negative mutants of small GTPases Rac and Ras, but not Rho, also attenuated RANK activation of JNK. In addition, RANK was found to cause AP-1 activation that seemed to be linked to JNK pathways, because the signaling molecule mutants with dominant negative effects on RANK activation of JNK also exerted inhibitory effects on AP-1 activation by RANK. Furthermore, the catalytic activities JNK and ERK, but not that of p38, was found to be required for the RANK induction of AP-1 activity.
Materials and Methods
Expression Plasmids. Mammalian expression vectors for T7-tagged human RANK, Flag-tagged TRAFs, GST-JNK1, and GST-SEK-KR, and prokaryotic GST-c-Jun-77 constructs were previously described . Expression plasmids for NIK-KK/AA [429] [430] and ASK1-KM were generous gifts from Drs. H. Y. Song (Lilly Co. Center, Indianapolis, IN) and H. Ichijo (Tokyo Medical and Dental University, Tokyo, Japan), respectively. MEKK-K432A (Xia et al., 1995) , JNK-APF , ERK1-KR (Butch and Guan, 1996) , and ERK2-KR (Her et al., 1993) have been described. The dominant negative mutants Rac1-N17, RhoA-N19, and Ras-N17 were kindly provided by Dr. J. S. Gutkind (National Institutes of Health, Bethesda, MD) and have been described (Coso et al., 1995 5 /well). The next day, cells were transfected with 0.3 to 0.5 g of pEBG-JNK and other indicated DNAs plus 8 l of SuperFect reagent (Qiagen, Chatsworth, CA) following the manufacturer's instruction. The total amounts of DNA were kept constant by adding control vector DNAs. Twenty to 36 h after transfection, cells were lysed in a lysis buffer (20 mM Tris-Cl, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 2 mM sodium orthovanadate, 50 mM sodium fluoride, 2 g/ml pepstatin A, 10 g/ml aprotinin, 10 g/ml leupeptin, pH 7.4) and centrifuged for 10 min at 10,000g. Cleared lysates (300 g) were incubated with glutathione beads for 2 h at 4°C. The precipitated beads were extensively washed and subjected to kinase reactions as previously described (Kim et al., 1998) .
RANK Ligand Stimulation. RANKL stimulation was performed using stable cell lines established by transfecting the full-length human RANKL (pCEP4-RANKL) or the control (pCEP4) vector into 293-EBNA and selecting cells in medium containing 250 g/ml hygromycin and G418. Cells were lysed in a hypotonic lysis buffer (10 mM Tris-HCl, pH7.4, 60 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 1 mM sodium vanadate, 1 mM sodium fluoride, 10 g/ml aprotinin, 10 g/ml leupeptin, and 2 mM phenylmethylsulfonyl fluoride), and unbroken cells and nuclei were removed by centrifugation for 5 min at 500g. The supernatants were centrifuged for 10 min at 10,000g, and the pellet fractions were used as crude membrane preparations to stimulate RANK-transfected 293-EBNA cells. RANK stimulation was also carried out with recombinant RANKL proteins immobilized on agarose beads. The entire extracellular domain of RANKL was amplified by polymerase chain reaction and subcloned into pET21a (Novagen, Madison, WI). The transformed Escherichia coli were cultured and induced with 0.1 mM isopropyl ␤-D-thiogalactoside for 2 h at 37°C. Cell pellets were disrupted by sonication, and the His-tagged RANKL was allowed to bind His⅐Bind resins (Novagen). The beads were extensively washed and used for stimulation of cells.
Reporter Gene Assays. Cells (1.5 ϫ 10 5 ) were plated onto 24-well plates 1 day before transfection with 100 to 200 ng of pAP1-Luc or pNF-B-Luc and indicated amounts of various constructs, keeping the ratio of DNA:SuperFect reagent (Qiagen) at 1:2 or 1:3. Fifty nanograms of a ␤-gal vector was cotransfected for normalizing transfection efficiencies. The total amounts of DNA were kept constant by supplementing with control vector DNAs. Sixteen to 20 h after transfection, cells were lysed with 150 l of Reporter Lysis Buffer (Promega, Madison, WI), and 20 l of lysates were used for detection of luciferase activity with Luminometer (EG&G Berthold, Bad Wildbad, Germany). In experiments with the p38 inhibitor SB 202190 (Calbiochem, San Diego, CA) and the PI 3-kinase inhibitor wortmannin (Sigma, St. Louis, MO), cells were incubated with the inhibitor 16 or 4 h after transfection for 2 to 16 h and harvested at the time point of 20 to 24 h post-transfection.
Western Blotting Analyses. Cell lysates were prepared as above, resolved by SDS-polyacrylamide gel electrophoresis, and transferred to a polyvinylidene difluoride membrane. The membrane was blocked for 1 h in TBS-T (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20) plus 3% skim milk, incubated with anti-RANK, anti-T7 (Novagen), anti-RANKL, anti-Flag M2 (Sigma), anti-GST, or anti-hemagglutinin (12CA5), washed for 1 h in TBS-T, and incubated with anti-mouse Ig-or anti-rabbit Ig-horseradish peroxidase for 1 h. The immune complexes were detected by the ECL system (Amersham). Generation of anti-RANK has been described , and anti-RANKL rabbit serum was generated by a similar method using GST fusion proteins of the extracellular domain of human RANKL as the immunogen. (Fig. 1C) . The expression of RANKL in the membrane preparations used for stimulation of the RANK-transfected cells was confirmed by Western blotting with anti-RANKL sera raised against the extracellular domain of RANKL (Fig. 1D) .
Inhibition of the RANK Activation of JNK by Dominant Negative Mutants of TRAF2, TRAF6, ASK, MEKK, NIK, Rac, and Ras. To identify the signaling components involved in the RANK-induced JNK activation, dominant negative mutant forms of signaling molecules that have been implicated in JNK activation pathways for other receptors were utilized. Studies with dominant negative TRAF2 (amino acids 87-501, lacking the N-terminal ring finger motif) in transgenic mice and cultured cell line systems have indicated that TRAF2 is essential for TNF-stimulated JNK activation Natoli et al., 1997) . When the dominant negative TRAF2 was cotransfected with RANK, the RANKinduced JNK activation was abolished ( Fig. 2A, top) . The TRAF6 mutant (amino acids 273-522), in which both the ring and zinc finger motifs are deleted, also showed some inhibitory effect. The expression of the wild-type TRAF1, the TRAF member naturally lacking the ring finger motif, almost completely inhibited the JNK activation by RANK. A dominant negative TRAF5 (amino acids 251-548) had little effect, and the full-length TRAF3 had a marginal effect ( Fig. 2A, top) . The lack of inhibitory effect of TRAF5 mutant was not due to any defect of the plasmid, because its expression was detected at a level similar to all other TRAF plasmids used ( Fig.  2A, bottom) , and also the cotransfection of the TRAF5 mutant resulted in the inhibition of RANK-induced NF-B activation (data not shown).
ASK1 has been demonstrated to be necessary for the TNFand TRAF2-induced JNK activation (Nishitoh et al., 1998) . In addition, the MEKK1-SEK1-JNK cascade has been demonstrated to be activated upon TNF stimulation (Yuasa et al., 1998) . To test the possibility of ASK1 involvement in the JNK activation by RANK, the kinase-inactive ASK1 mutant (ASK-KM) was cotransfected with RANK, and the JNK activity was assessed. Overexpression of ASK-KM significantly decreased the RANK-induced JNK activation (Fig. 2B) . When the catalytically inactive MEKK1 and SEK1 were tested for effects on the RANK-dependent JNK activation, both of them suppressed the kinase activity (Fig. 2C) . JNK activity has also been shown to be regulated by small GTPases Rac, Cdc42, and Ras (Coso et al., 1995; Minden et al., 1995) . Whether the small GTP-binding proteins are involved in the RANK-induced JNK activation was assessed by cotransfecting the dominant negative forms of Rac1, RhoA, and Ras. Dominant negative Rac1-N17 and Ras-N17 inhibited RANK stimulation of JNK activity (Fig. 2D, lanes 3 and 5) , whereas cotransfection of the RhoA-N19 mutant did not have significant effect (lane 4). Cross-talk between two major TNF signaling pathways, the NIK-IKK-NFB and MEKK-SEK-JNK pathways, has been suggested, and overexpression of NIK was shown to result in JNK activation (Karin and Delhase, 1998) . The possibility that the RANK-induced JNK activation is regulated by NIK was explored by cotransfecting the kinase-inactive NIK mutant (NIK-KKAA [429] [430] ) that suppressed RANK activation of NF-B under similar transfection conditions (data not shown). The expression of NIK-KKAA 429-430 significantly reduced the JNK activation by RANK (Fig. 2D, lane 6) . PI 3-kinase has been shown to play a role in the JNK activation pathway for receptor tyrosine kinases, perhaps through Rac (Logan et al., 1997; Timokhina et al., 1998) . To determine whether PI 3-kinase is involved in the RANK-induced JNK activation, wortmannin, an inhibitor specific for PI 3-kinase at concentrations below 200 nM, was used. As shown in Fig. 2E , wortmannin had no effect on RANK activation of JNK in these cells at doses known to be sufficient for PI 3-kinase inhibition.
Induction of AP-1 Activity by RANK and Involvement of TRAF Proteins. JNK activation has been linked to transactivation of the AP-1 transcription complexes . The observation that RANK can stimulate JNK signaling pathways in which TRAF proteins, serine/ threonine kinases, and GTP-binding proteins are involved prompted us to determine the AP-1-activating potential of RANK and to evaluate the role of these signaling components. When overexpressed in human embryonic kidney cells, RANK caused induction of an AP-1-responsive reporter gene as efficiently as TRAF2 (Fig. 3A) . This AP-1 activation by RANK correlated with the amounts of transfected RANK DNA (Fig. 3B) . We next included N-terminal truncation mutants of TRAFs that have been shown to have dominant negative effects on NF-B activation. The TRAF2 and TRAF5 mutants abolished the RANK-induction of AP-1 activity, and the TRAF6 mutant had a significant inhibitory effect (Fig.  3C) . In these cells the TRAF mutants also inhibited RANK activation of NF-B (Fig. 3D) . In the absence of RANK, the TRAF6 deletion mutant itself exerted some activation of AP-1, albeit to a lower extent than the wild-type TRAF6 (data not shown). The cotransfection of wild-type TRAF1 or TRAF3 also resulted in reduction of the AP-1 activation by RANK (data not shown).
Involvement of ASK1 and NIK in RANK-Induced AP-1 Activation. To determine signaling components downstream of TRAF proteins in RANK activation of AP-1, kinaseinactive mutants of ASK1, NIK, and MEKK1, which all showed inhibitory effects on RANK stimulation of JNK activity, were tested for the AP-1-derived reporter gene induction. As shown in Fig. 4A , the kinase-null mutants ASK1-KM and NIK-KKAA showed significant inhibitory effect on RANK-induced AP-1 activation. The role of MEKK1 in AP-1 activation by RANK could not be assessed, because transfection of the kinase domain mutant of MEKK1 itself evoked a high level of AP-1 activation under the experimental conditions (data not shown). Transfection of various amounts of ASK1-KM and NIK-KKAA showed dose-dependent inhibitory effects (Fig. 4, B and C) . The role of immediate upstream JNK kinase SEK was also evaluated by using the kinaseinactive mutant SEK-KR that was previously shown to inhibit RANK-induced JNK activation . The cotransfection of SEK-KR mutant resulted in suppression of the AP-1 activation by RANK (Fig. 4D) .
Differential Regulation of RANK Activation of AP-1 by MAPK Family Enzymes. The inhibitory effect of ASK1-KM and SEK1-KR on RANK-induced AP-1 activation (Fig. 4 , B and D) directed us to assess the involvement of JNK in AP-1 activation of RANK. Two additional MAPK family enzymes, ERK and p38, were also examined. As might be expected, cotransfection of JNK1-APF, a JNK1 mutant containing substitutions in the TPY residues that are to be phosphorylated by upstream activating kinases upon stimulatory signals, into 293-EBNA cells led to the reduction in RANK-induction of AP-1 activity (Fig. 5A ). In addition, kinase-inactive mutants of ERKs were found to attenuate the AP-1 activation by RANK in these cells, and the ERK2 mutant was more effective than the ERK1 mutant (Fig. 5B) . The ERK2-KR also efficiently suppressed the AP-1 activation induced by NIK or TRAF6 (data not shown). The role of p38 MAPK family kinase was determined by treating RANKtransfected cells with a specific p38 inhibitor SB202190. Treatment of the cells with the p38 inhibitor for 4 h had no effect on the RANK-induced AP-1 activation even at a dose 57-fold higher than the IC 50 (350 nM) (Fig. 5C ). Variation in the treatment time did not affect the result (data not shown). These observations indicate that the RANK-to-AP-1 signaling pathway is independent of p38 MAPK activity.
Inhibition of RANK Activation of AP-1 by Interference of Rac and Ras but Not That of Rho and PI 3-Kinase. We next evaluated the role of Ras family of GTPbinding proteins and PI 3-kinase in the RANK-induced AP-1 activation. The dominant negative mutant of Rac1, RhoA, or Ras was cotransfected with RANK and AP-1-dependent reporter gene, and the reporter activity was examined. Transfection of dominant negative Rac1 and Ras resulted in reduction in the RANK activation of AP-1 by 33 and 50%, respectively (Fig. 6A) . In contrast, dominant negative RhoA showed no inhibition under the same experimental conditions (Fig. 6A) . Treatment of cells with a specific PI 3-kinase inhibitor wortmannin also did not inhibit the RANK activation of AP-1 at concentrations up to 40-fold higher than IC 50 (5 nM), which suggested that the catalytic activity of PI 3-kinase is not involved in RANK activation of the AP-1 transcription factor in these cells (Fig. 6B) .
Discussion
Activation of JNK is one of the major biochemical consequences of stimulation of TNF receptor family proteins such as TNFR1, TNFR2, CD95 (Fas/Apo-1), CD40, and CD27. For TNF-stimulation of JNK activity, TRAF2 seems to be essential, as demonstrated by studies with TRAF2 knock-out and dominant negative TRAF2 transgenic mice Yeh et al., 1997) , whereas Fas-induced JNK activation was shown to be mediated by the Fas-binding protein Daxx (Yang et al., 1997) . Both TRAF2 and TRAF5 were reported to be involved in CD27-induced JNK activation (Akiba et al., 1998; Gravestein et al., 1998) . In B cells, CD40 activation of JNK has been shown to be mediated by TRAF3 (Grammer et al., 1998) . Recently, TRAF1 was implicated in prolonging TNFinduced JNK activation (Schwenzer et al., 1999) . Overexpression of TRAF2, -5, or -6 could also evoke JNK activation in 293 cells (Song et al., 1997) . Taken together different TRAF family proteins and perhaps complexes of them may have capacity to transduce JNK activating signals from various TNFR family members in different cellular environments. The role of TRAF family proteins in RANK-induced JNK activation has not been reported to date. In this study, we found that expression of N-terminal deletion mutant of TRAF2, and to a lesser extent that of TRAF6, inhibited RANK activation of JNK ( Fig. 2A) , implicating these TRAF members in JNK activation by RANK. These TRAF proteins as well as TRAF1, Ϫ3, and Ϫ5 were shown to associate with RANK in cultured cells (Darnay et al., 1998; Kim et al., 1999) , and N-terminal deletion mutants of TRAF2, -5, and -6 have been demonstrated to have the dominant negative effect on NF-B activation Kim 1999) . However, the relative contribution of TRAF2 and TRAF6 to the RANKinduced JNK and NF-B activation pathways appears to be different, because the dominant negative TRAF2 mutant was more effective than the dominant negative TRAF6 in blocking JNK activation, whereas with the same mutant constructs the reverse was observed in the context of NF-B activation by RANK under similar experimental conditions ( Figs. 2A and 3D) .
Several MAPK cascade enzymes have been implicated in the signaling of TNF family receptors to JNK. Some of these JNK-activating kinases have been suggested to work immediately downstream of TRAF proteins. The ASK1 and NIK proteins were shown to bind TRAF1, -2, -3, -5, and -6 and the Fig. 3 . Activation of AP-1 by RANK and its inhibition by N-terminal deletion mutants of TRAF2, -5, and -6. A, 293-EBNA cells in 24-well plates were transfected with 0.5 g of the indicated plasmids, 0.1 g of pAP1-Luc, and 50 ng of ␤-gal. Sixteen hours post-transfection, cell lysates were prepared and luciferase activity was measured. IL-1R, interleukin-1 receptor. B, cells were transfected as in A with the indicated amounts of pSR␣-RANK-T7. The total amounts of DNA were kept constant by adding pSR␣ vector DNA. Cell lysates were prepared, and the AP-1 activity was determined. C, cells were cotransfected with 1.0 g of pSR␣ or pSR␣-RANK-T7 and 1.0 g of the indicated TRAF mutant together with 0.2 g of pAP1-Luc and 50 ng of ␤-gal. The next day, cell lysates were prepared, and luciferase activity was assessed. D, cells were transfected with 0.5 g of pSR␣ or pSR␣-RANK-T7 and 0.5 g of the TRAF mutant together with 0.1 g of pNF-B-Luc and 50 ng of ␤-gal. The next day, luciferase activity was measured from cell lysates. Error bars indicate standard deviations between triplicate samples and the data represent one of three independent experiments.
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at ASPET Journals on August 27, 2017 molpharm.aspetjournals.org Downloaded from MEKK1 and GCK proteins to TRAF2 (Song et al., 1997; Nishitoh et al., 1998; Yuasa et al., 1998) . All of these kinases were shown to mediate JNK activation through TRAF2 for TNF or CD27 signaling (Akiba et al., 1998; Nishitoh et al., 1998; Yuasa et al., 1998) . The expression of kinase-inactive mutants of ASK1, MEKK1, or NIK inhibited RANK-induced JNK activation (Fig. 2) , suggesting that RANK could engage, perhaps through TRAF2, these kinases for JNK pathway signaling. MEKK1 has been shown to bind the JNK-activating small GTP-binding proteins Rac, Cdc42, and Ras (Russell et al., 1995; Fanger et al., 1997) , which have been implicated in cytokine-and growth factor-induced JNK activation (Coso et al., 1995; Minden et al., 1995) . In RANK signaling, Rac and Ras, but not Rho, seem to be involved, because the dominant negative mutants of the former, but not the latter, interfered RANK-induced JNK activation (Fig. 2D) . Although PI 3-kinase has been implicated in the Rac-mediated JNK activation in some cases (Timokhina et al., 1998) , the JNK activation by RANK appeared to be independent of PI 3-kinase. Taken together, these results would suggest that RANK signaling to JNK is mediated by TRAF2-ASK1/MEKK1/NIK-SEK cascades with the TRAF2-to-ASK1/MEKK1/NIK steps possibly being modulated by Rac and Ras. However, more questions, such as the relative contributions of ASK1, MEKK1, and NIK, the participation of other TRAF proteins in linking RANK to the kinases, the immediate downstream target of NIK for JNK activation, and the exact target of Rac and Ras in modulation of the RANK-to-JNK signaling, remain to be addressed.
JNK regulates the AP-1 transcription factor by phosphorylating the c-Jun component on Ser-63 and Ser-73 residues . We found that RANK could evoke AP-1 transactivation, which was regulated by TRAF2, ASK1, NIK, SEK1, Rac, and Ras, signaling components involved in the RANK activation of JNK (Figs. 3, 4 , and 6). The role of NIK in the activation of JNK and AP-1 for TNF family receptors has not been clearly resolved. In some studies, NIK appeared to have no effect on TNF-and TRAF2-induced JNK activity (Song et al., 1997; Karin and Delhase, 1998) and to cause AP-1 activation in JNK-independent manner (Natoli et al., 1997) , whereas in other studies, NIK seemed to mediate JNK activation by CD27 (Akiba et al., 1998) and have JNKactivating potential under high expression conditions (Karin and Delhase, 1998) . The role of the JNK pathway in RANKinduced AP-1 activation was further supported by the interference of the JNK-APF mutant, which is incapable of receiving activating signals (Fig. 5A) . Another MAPK pathway also seemed to participate in RANK activation of AP-1. The impedance of ERK, but not that of p38, was found to affect AP-1 activation (Fig. 5, B and C) . ERK activity can positively regulate AP-1 by phosphorylating target transcription factors. Phosphorylation of Elk-1 by ERK increases formation of the ternary complex between Elk-1 and a homodimer of serum response factor that binds the serum response element to induce c-fos (Gille et al., 1995) , and the c-fos protein itself has been shown to be stabilized upon phosphorylation by ERK (Okazaki and Sagata, 1995) . ERK has been reported to be activated by CD40 through TRAF6 (Kashiwada et al., 1998) . AP-1 activation through the ERK-dependent pathway may also account for the inhibitory effect of TRAF5 mutant on AP-1 activation (Fig. 3C ) in the absence of an effect on JNK activation by RANK (Fig. 2A) . Whether RANK can activate ERK and whether TRAF5 and TRAF6 are involved in that are under investigation.
Activation of Ras can lead to stimulation of both the ERK and JNK subfamily enzymes of MAPKs .
The Ras stimulation of ERK activity is mediated by the Ras-Raf-MEK pathway, whereas the JNK activation signal from Ras seems to be transduced by the MEKK1-SEK cascade. Ras may regulate the RANK induction of AP-1 through both JNK and ERK pathways. This notion may be supported by the finding that the dominant negative Ras was more effective than that of Rac in attenuating the RANK activation of AP-1 (Fig. 3B) , whereas both mutants inhibited the RANK-induced JNK activation to the same extent ( Fig. 2A) .
Our results provide information based on which a potential mechanism for signaling from RANK to JNK and to AP-1 is proposed (Fig. 7) . It is postulated that RANK is linked to redundant JNK-activating pathways through TRAF2 and possibly TRAF6. The TRAF proteins can associate with ASK1, MEKK1, and NIK to activate SEK, which, in turn, activates JNK. The small GTP-binding proteins Rac and Ras regulate JNK and AP-1 activation, perhaps by modulating the step at which TRAFs activate MAPKKKs. RANK also couples to ERK for AP-1 activation, although the pathway remains to be unraveled. For better understanding of RANK signal transduction, further studies of the signaling components involved in AP-1 activation through ERK and the pos- sibility of cross-talk between pathways for the activation of JNK, ERK, and NF-B will be required. Also, verification of the pathways that have been identified to mediate RANK signaling using overexpression systems under more normal conditions, such as in dendritic cells or osteoclasts, will facilitate the linking of these signaling pathways to physiological functions of RANK. 
